Literature DB >> 17319269

Severe acute respiratory syndrome--retrospect and lessons of 2004 outbreak in China.

Wan-Nian Liang1, Tao Zhao, Ze-Jun Liu, Bao-Ying Guan, Xiong He, Min Liu, Qi Chen, Gai-Fen Liu, Jiang Wu, Ruo-Gang Huang, Xue-Qin Xie, Zheng-Lai Wu.   

Abstract

OBJECTIVE: To summarize lessons learned from an outbreak of severe acute respiratory syndrome (SARS) in China during the spring of 2004.
METHODS: Data of SARS cases were officially reported by Beijing Municipal Center for Disease Control and Prevention (BCDC) and Anhui Provincial Center for Disease Control and Prevention (APCDC) and results of epidemiological investigations were collected and analyzed.
RESULTS: Three generations of 11 cases of SARS were identified during the outbreak. Initial two cases were most likely to be infected in Diarrhea Virus Laboratory of National Institute of Virology, China Centers for Disease Control and Prevention and main mode of transmission was direct contact with SARS patients. Delay in detecting initial case resulted in spread of the illness at hospitals and communities with two generations of secondary cases.
CONCLUSIONS: SARS outbreak in 2004 has yielded following lessons for public health globally. (1) Lab bio-safety programs should be made and should be strictly abided by. Studies in highly pathogenic viruses such as SARS coronavirus should be utmost cautious. (2) Management systems of occupational exposure to virus and disease surveillance need to be strengthened to take all risk factors into account so as to detect potential patients with infectious disease as early as possible.

Entities:  

Mesh:

Year:  2006        PMID: 17319269

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  7 in total

Review 1.  Two Years into the COVID-19 Pandemic: Lessons Learned.

Authors:  Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Renata Pessôa Germano Mendes; Klarissa Miranda Guarines; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Jurandy Júnior Ferraz de Magalhães; Justin R J Vigar; Abelardo Silva-Júnior; Alain Kohl; Keith Pardee; Lindomar Pena
Journal:  ACS Infect Dis       Date:  2022-08-08       Impact factor: 5.578

Review 2.  Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV.

Authors:  Disha Panchal; Jeena Kataria; Kamiya Patel; Kaytlyn Crowe; Varun Pai; Abdul-Rahman Azizogli; Neil Kadian; Sreya Sanyal; Abhishek Roy; Joseph Dodd-O; Amanda M Acevedo-Jake; Vivek A Kumar
Journal:  Adv Ther (Weinh)       Date:  2021-08-06

3.  Biosecurity and biosafety in research on emerging pathogens.

Authors:  Lu Lu; Qi Liu; Shibo Jiang
Journal:  Emerg Microbes Infect       Date:  2012-11-21       Impact factor: 7.163

4.  Transmission of pandemic influenza A (H1N1) virus in a train in China.

Authors:  Fuqiang Cui; Huiming Luo; Lei Zhou; Dapeng Yin; Canjun Zheng; Dingming Wang; Jian Gong; Gang Fang; Jianfeng He; Jeffrey McFarland; Hongjie Yu
Journal:  J Epidemiol       Date:  2011-06-04       Impact factor: 3.211

Review 5.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

Review 6.  Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019.

Authors:  Ernest Spitzer; Ben Ren; Jasper J Brugts; Joost Daemen; Eugene McFadden; Jan Gp Tijssen; Nicolas M Van Mieghem
Journal:  Card Fail Rev       Date:  2020-05-01

7.  Coronavirus disease 2019 (COVID-19) outbreak: Could pigs be vectors for human infections?

Authors:  Tanja Opriessnig; Yao-Wei Huang
Journal:  Xenotransplantation       Date:  2020-03-28       Impact factor: 3.907

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.